{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:15:16Z","timestamp":1788336916799,"version":"build-2803163510"},"reference-count":106,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Veterinary Sciences"],"abstract":"<jats:p>Pituitary pars intermedia dysfunction (PPID) is a common, slowly progressive, neurodegenerative disorder of the older horse. Oxidative damage to the hypothalamic periventricular neurons results in loss of dopaminergic inhibition of the pars intermedia region of the pituitary gland. Consequently, there is increased production of the pro-opiomelanocortin (POMC)-derived hormones normally produced by this region, as well as initial melanocyte hypertrophy and hyperplasia, followed by adenomatous change. Clinical signs that are highly suggestive of the disease are generalised and regional hypertrichosis and delayed\/abnormal coat shedding. Numerous clinical signs provide a moderate clinical suspicion, including hyperhidrosis, abnormal fat distribution\/regional adiposity, epaxial muscle atrophy\/loss of topline, laminitis, weight loss, recurrent infections, behavioural changes\/lethargy, polyuria and polydipsia, a pot-bellied appearance, bulging supraorbital fat pads, reduced wound healing, lordosis and infertility. In all animals, a diagnosis of PPID is made based on the signalment, clinical signs and results of further diagnostic tests, with age being a crucial factor to consider. Currently recommended further diagnostic tests are measurement of basal adrenocorticotrophic hormone (ACTH) concentrations (all year) and evaluation of the ACTH response to thyrotrophin-releasing hormone (TRH) using seasonally adjusted references intervals (non-autumn). Animals should also be tested for insulin dysregulation, as laminitis risk in PPID is associated with hyperinsulinaemia. PPID can be managed but not cured; it is a lifelong condition. The individual clinical signs can be managed, e.g., clipping the excessive haircoat and providing unrestricted access to water for individuals with polydipsia. Alternatively, pharmacological management can be employed, and the dopamine-2 receptor agonist pergolide is licensed\/approved for the treatment of equine PPID. This should be prescribed in combination with dietary recommendations based on the body condition score and insulin sensitivity status of the individual animal.<\/jats:p>","DOI":"10.3390\/vetsci12080780","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T08:02:44Z","timestamp":1755763364000},"page":"780","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Equine Pituitary Pars Intermedia Dysfunction"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3803-8069","authenticated-orcid":false,"given":"Nicola J.","family":"Menzies-Gow","sequence":"first","affiliation":[{"name":"Department of Clinical Science and Services, Royal Veterinary College, Hawkshead Lane, North Mymms, Hertfordshire AL9 7TA, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.arr.2007.02.001","article-title":"Advantages and limitations of the equine disease, pituitary pars intermedia dysfunction as a model of spontaneous dopaminergic neurodegenerative disease","volume":"6","author":"McFarlane","year":"2007","journal-title":"Ageing Res. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.rvsc.2022.08.018","article-title":"Correlation of pituitary histomorphometry with dopamine and dopamine D2 receptor expression in horses with pituitary pars intermedia dysfunction","volume":"152","author":"Huang","year":"2022","journal-title":"Res. Vet. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2460\/ajvr.2005.66.2055","article-title":"Agreement in histologic assessments of the pituitary pars intermedia in aged horses","volume":"66","author":"McFarlane","year":"2005","journal-title":"Am. J. Vet. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/030098589902700606","article-title":"Immunocytochemical demonstration of proopiomelanocortin-derived peptides in pituitary adenomas of the pars intermedia in horses","volume":"27","author":"Heinrichs","year":"1990","journal-title":"Vet. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/endo-110-3-941","article-title":"Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing\u2019s horses","volume":"110","author":"Wilson","year":"1982","journal-title":"Endocrinology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/evj.14009","article-title":"BEVA primary care clinical guidelines: Diagnosis and management of equine pituitary pars intermedia dysfunction","volume":"56","author":"Banse","year":"2024","journal-title":"Equine Vet. J."},{"key":"ref_7","unstructured":"Hart, K., Bertin, F.R., Durham, A.E., Frank, N., McGowan, C.M., Schott, H.C., and Stewart, A.J. (2025, July 17). Recommendations for the Diagnosis and Management of Pituitary Pars Intermedia Dysfunction (PPID). Available online: https:\/\/www.gddiergezondheid.nl\/-\/media\/Files\/Flyers-producten\/flyers-Paard\/PPID-Recommendations.pdf."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2746\/0425164044877288","article-title":"Serum insulin concentrations in horses with equine Cushing\u2019s syndrome: Response to a cortisol inhibitor and prognostic value","volume":"36","author":"McGowan","year":"2004","journal-title":"Equine Vet. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/evj.13041","article-title":"Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction","volume":"51","author":"Horn","year":"2019","journal-title":"Equine Vet. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/evj.12963","article-title":"Association between hyperinsulinaemia and laminitis severity at the time of pituitary pars intermedia dysfunction diagnosis","volume":"51","author":"Tadros","year":"2019","journal-title":"Equine Vet. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000126214","article-title":"Evidence that hypothalamic periventricular dopamine neurons innervate the intermediate lobe of the rat pituitary","volume":"56","author":"Goudreau","year":"1992","journal-title":"Neuroendocrinology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2460\/ajvr.1999.60.02.245","article-title":"Regulation of alpha-melanocyte-stimulating hormone secretion from the pars intermedia of domestic cats","volume":"60","author":"Kemppainen","year":"1999","journal-title":"Am. J. Vet. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/endo-124-5-2208","article-title":"Regulation and secretion of proopiomelanocortin peptides from isolated perifused dog pituitary pars intermedia cells","volume":"124","author":"Kemppainen","year":"1989","journal-title":"Endocrinology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1939-1676.2005.tb02685.x","article-title":"Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age, and sex in healthy ponies and horses","volume":"19","author":"Donaldson","year":"2005","journal-title":"J. Vet. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.rvsc.2011.05.013","article-title":"Cortisol, adrenocorticotropic hormone, serotonin, adrenaline and noradrenaline serum concentrations in relation to disease and stress in the horse","volume":"93","author":"Ayala","year":"2012","journal-title":"Res. Vet. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/endo-128-1-65","article-title":"The effect of acute exercise on the secretion of corticotropin-releasing factor, arginine vasopressin, and adrenocorticotropin as measured in pituitary venous blood from the horse","volume":"128","author":"Alexander","year":"1991","journal-title":"Endocrinology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2460\/javma.241.2.241","article-title":"Seasonal variation in results of diagnostic tests for pituitary pars intermedia dysfunction in older, clinically normal geldings","volume":"241","author":"Schreiber","year":"2012","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1111\/jvim.14782","article-title":"The Effect of Geographic Location on Circannual Adrenocorticotropic Hormone Plasma Concentrations in Horses in Australia","volume":"31","author":"Secombe","year":"2017","journal-title":"J. Vet. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1111\/jvim.15620","article-title":"Cortisol and adrenocorticotropic hormone concentrations in horses with systemic inflammatory response syndrome","volume":"33","author":"Stewart","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2826.2005.01277.x","article-title":"Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction","volume":"17","author":"McFarlane","year":"2005","journal-title":"J. Neuroendocrinol."},{"key":"ref_21","first-page":"664","article-title":"Bioactivity of Plasma Acth from Horses with Ppid Compared to Normal Horses","volume":"25","author":"Cordero","year":"2011","journal-title":"J. Vet. Intern. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1939-1676.2011.00810.x","article-title":"Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction","volume":"25","author":"Beech","year":"2011","journal-title":"J. Vet. Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/en.2018-00726","article-title":"Dysregulation of Cortisol Metabolism in Equine Pituitary Pars Intermedia Dysfunction","volume":"159","author":"Morgan","year":"2018","journal-title":"Endocrinology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Fortin, J.S., Hetak, A.A., Duggan, K.E., Burglass, C.M., Penticoff, H.B., and Schott, H.C. (2021). Equine pituitary pars intermedia dysfunction: A spontaneous model of synucleinopathy. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-95396-7"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2460\/javma.2003.223.93","article-title":"Demographic and clinical characteristics of geriatric horses: 467 cases (1989-1999)","volume":"223","author":"Brosnahan","year":"2003","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prevetmed.2016.07.011","article-title":"Prevalence, survival analysis and multimorbidity of chronic diseases in the general veterinarian-attended horse population of the UK","volume":"131","author":"Welsh","year":"2016","journal-title":"Prev. Vet. Med."},{"key":"ref_28","unstructured":"Chandler, K.J., and Mellor, D.J. (, January September). A pilot study of the prevalence of disease within a geriatric horse population. Proceedings of the 40th Congress of the British Equine Veterinary Association, Harrogate, UK."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1939-1676.2012.00932.x","article-title":"Diagnostic frequency, response to therapy, and long-term prognosis among horses and ponies with pituitary par intermedia dysfunction, 1993-2004","volume":"26","author":"Rohrbach","year":"2012","journal-title":"J. Vet. Intern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.2042-3306.2012.00578.x","article-title":"Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses","volume":"45","author":"McGowan","year":"2013","journal-title":"Equine Vet. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1939-1676.1996.tb02016.x","article-title":"Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism","volume":"10","author":"Couetil","year":"1996","journal-title":"J. Vet. Intern. Med."},{"key":"ref_32","first-page":"742","article-title":"Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing\u2019s disease)","volume":"16","author":"Donaldson","year":"2002","journal-title":"J. Vet. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0021-9975(08)80260-5","article-title":"Equine pituitary adenoma: A functional and morphological study","volume":"109","author":"Boujon","year":"1993","journal-title":"J. Comp. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.2042-3292.1992.tb01595.x","article-title":"Diagnosis of hyperadrenocorticism in the horse","volume":"4","author":"Hillyer","year":"1992","journal-title":"Equine Vet. Educ."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/0300985815608674","article-title":"What\u2019s New in Old Horses? Postmortem Diagnoses in Mature and Aged Equids","volume":"53","author":"Miller","year":"2016","journal-title":"Vet. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mendoza, F.J., Toribio, R.E., and Perez-Ecija, A. (2024). Metabolic and Endocrine Insights in Donkeys. Animals, 14.","DOI":"10.3390\/ani14040590"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"(2006). Results of post mortem examinations at the Donkey Sanctuary. Vet. Rec., 159, 582.","DOI":"10.1136\/vr.159.18.582"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcpa.2010.08.005","article-title":"Retrospective analysis of post-mortem findings in 1,444 aged donkeys","volume":"144","author":"Morrow","year":"2011","journal-title":"J. Comp. Pathol."},{"key":"ref_39","unstructured":"Svensden, E.D., Duncan, J., and Hadrill, D. (2008). The care of the geriatric donkey. The Professional Handbook of the Donkey, Whitted Books."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tvjl.2018.03.002","article-title":"Epidemiology of pituitary pars intermedia dysfunction: A systematic literature review of clinical presentation, disease prevalence and risk factors","volume":"235","author":"Ireland","year":"2018","journal-title":"Vet. J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0007-1935(05)80084-3","article-title":"Equine Cushing\u2019s disease","volume":"149","author":"Love","year":"1993","journal-title":"Br. Vet. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"721","DOI":"10.21836\/PEM20130606","article-title":"Use of the chasteberry preparation Corticosal((R)) for the treatment of pituitary pars intermedia dysfunction in horses","volume":"29","author":"Bradaric","year":"2013","journal-title":"Pferdeheilkunde"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/evj.12089","article-title":"Severe hypertriglyceridaemia in horses and ponies with endocrine disorders","volume":"46","author":"Dunkel","year":"2014","journal-title":"Equine Vet. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"538","DOI":"10.21836\/PEM20180605","article-title":"Effects of the multi-compound complex in Corticosal (R) in 177 horses with PPID in a retrospective veterinary questionnaire analysis in Germany","volume":"34","author":"Schramm","year":"2018","journal-title":"Pferdeheilkunde"},{"key":"ref_45","first-page":"24","article-title":"Prevalence of equine Cushing\u2019s syndrome among older horses in Southern Vestsj\u00e6lland, Denmark","volume":"92","author":"Christiansen","year":"2009","journal-title":"Dansk Veterin\u00e6rtidsskrift"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.12935\/jvma.65.771","article-title":"Two Cases of Equine Cushing\u2019s Disease in Thoroughbred Mares","volume":"65","author":"Nanao","year":"2012","journal-title":"J. Jpn. Vet. Med. Assoc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3390\/vetsci9100572","article-title":"Prospective Case Series of Clinical Signs and Adrenocorticotrophin (ACTH) Concentrations in Seven Horses Transitioning to Pituitary Pars Intermedia Dysfunction (PPID)","volume":"9","author":"Kirkwood","year":"2022","journal-title":"Vet. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/jvim.16145","article-title":"Relationship between endogenous plasma adrenocorticotropic hormone concentration and reproductive performance in Thoroughbred broodmares","volume":"35","author":"Tsuchiya","year":"2021","journal-title":"J. Vet. Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Nitzsche, A.M., Fey, K., Buttner, K., Grof, M., and Staszyk, C. (2021). The Gingiva of Horses With Pituitary Pars Intermedia Dysfunction: A Macroscopic Anatomical Evaluation. Front. Vet. Sci., 8.","DOI":"10.3389\/fvets.2021.786971"},{"key":"ref_50","unstructured":"Erdody, M., Galinelli, N., Bamford, N.J., Mackensie, S., Warnken, T., Harris, P.A., Sillence, M.N., and Bailey, S.R. (2023, January 3\u20135). Plasma immunoreactive \u03b2-endorphin concentrations and spontaneous blink rate as an index of stress, measured in a population of aged horses and ponies with and without PPID. Proceedings of the 5th Global equine endocrine symposium, Bern, Switzerland."},{"key":"ref_51","unstructured":"Grubbs, S.T., Neal, D.L., and Keefe, D.J. (2020, January 7\u20139). Development and evaluation of a clinical sign scoring system for pituitary pars intermedia dysfunction in horses. Proceedings of the 4th Global Equine Endocrine Symposium, Gut Ising, Germany."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/evj.13292","article-title":"Clinically and temporally specific diagnostic thresholds for plasma ACTH in the horse","volume":"53","author":"Durham","year":"2021","journal-title":"Equine Vet. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.domaniend.2011.05.004","article-title":"The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion\/referral equine hospital","volume":"41","author":"Karikoski","year":"2011","journal-title":"Domest. Anim. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/evj.12169","article-title":"Insulin dysregulation","volume":"46","author":"Frank","year":"2014","journal-title":"Equine Vet. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/evj.13572","article-title":"Predictors of laminitis development in a cohort of nonlaminitic ponies","volume":"55","author":"Knowles","year":"2023","journal-title":"Equine Vet. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1751-0813.2012.00997.x","article-title":"Case series of equine pituitary pars intermedia dysfunction in a tropical climate","volume":"90","author":"Spelta","year":"2012","journal-title":"Aust. Vet. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"106036","DOI":"10.1016\/j.tvjl.2023.106036","article-title":"Diagnosis of equine pituitary pars intermedia dysfunction","volume":"300\u2013302","author":"Stewart","year":"2023","journal-title":"Vet. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1354\/vp.45-1-26","article-title":"Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction","volume":"45","author":"Miller","year":"2008","journal-title":"Vet. Pathol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/jvim.16017","article-title":"Clinical implications of using adrenocorticotropic hormone diagnostic cutoffs or reference intervals to diagnose pituitary pars intermedia dysfunction in mature horses","volume":"35","author":"Horn","year":"2021","journal-title":"J. Vet. Intern. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/j.1939-1676.2011.0745.x","article-title":"The effect of geographic location, breed, and pituitary dysfunction on seasonal adrenocorticotropin and alpha-melanocyte-stimulating hormone plasma concentrations in horses","volume":"25","author":"McFarlane","year":"2011","journal-title":"J. Vet. Intern. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/evj.12745","article-title":"Effect of age and dietary carbohydrate profiles on glucose and insulin dynamics in horses","volume":"50","author":"Jacob","year":"2018","journal-title":"Equine Vet. J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2460\/ajvr.77.7.738","article-title":"Effects of withholding feed on thyrotropin-releasing hormone stimulation test results and effects of combined testing on oral sugar test and thyrotropin-releasing hormone stimulation test results in horses","volume":"77","author":"Restifo","year":"2016","journal-title":"Am. J. Vet. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.domaniend.2014.02.004","article-title":"Influence of feeding status, time of the day, and season on baseline adrenocorticotropic hormone and the response to thyrotropin releasing hormone-stimulation test in healthy horses","volume":"48","author":"Lopez","year":"2014","journal-title":"Domest. Anim. Endocrinol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1111\/jvim.16281","article-title":"Repeatability of a thyrotropin-releasing hormone stimulation test for diagnosis of pituitary pars intermedia dysfunction in mature horses","volume":"35","author":"Kam","year":"2021","journal-title":"J. Vet. Intern. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2460\/ajvr.76.5.437","article-title":"Evaluation of a thyrotropin-releasing hormone solution stored at room temperature for pituitary pars intermedia dysfunction testing in horses","volume":"76","author":"Goodale","year":"2015","journal-title":"Am. J. Vet. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"103810","DOI":"10.1016\/j.jevs.2021.103810","article-title":"Circulating Hypothalamic-Pituitary-Adrenal Axis Hormones and Insulin Concentrations in Horses and Ponies","volume":"111","author":"Vaughn","year":"2022","journal-title":"J. Equine Vet. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/avj.13022","article-title":"Circannual variation in plasma adrenocorticotropic hormone concentrations and dexamethasone suppression test results in Standardbred horses, Andalusian horses and mixed-breed ponies","volume":"98","author":"Bamford","year":"2020","journal-title":"Aust. Vet. J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"106620","DOI":"10.1016\/j.domaniend.2021.106620","article-title":"Markers of muscle atrophy and impact of treatment with pergolide in horses with pituitary pars intermedia dysfunction and muscle atrophy","volume":"76","author":"Banse","year":"2021","journal-title":"Domest. Anim. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1136\/vr.103274","article-title":"Venipuncture does not affect adrenocorticotropic hormone concentration in horses","volume":"177","author":"Fouche","year":"2015","journal-title":"Vet. Rec."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Gehlen, H., Jaburg, N., Merle, R., and Winter, J. (2020). Can Endocrine Dysfunction Be Reliably Tested in Aged Horses That Are Experiencing Pain?. Animals, 10.","DOI":"10.3390\/ani10081426"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"105857","DOI":"10.1016\/j.tvjl.2022.105857","article-title":"The effect of month and breed on plasma adrenocorticotropic hormone concentrations in equids","volume":"286","author":"Durham","year":"2022","journal-title":"Vet. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tvjl.2018.07.008","article-title":"Circannual variability in adrenocorticotropic hormone responses to administration of thyrotropin-releasing hormone in clinically normal horses in Australia","volume":"238","author":"Byrne","year":"2018","journal-title":"Vet. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"116","DOI":"10.36303\/JSAVA.001","article-title":"Temporally specific adrenocorticotropic hormone reference intervals for horses in South Africa","volume":"93","author":"Fisher","year":"2022","journal-title":"J. S Afr. Vet. Assoc."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/jvim.15617","article-title":"Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses","volume":"33","author":"Horn","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1046\/j.1365-2826.2003.01042.x","article-title":"Effects of novelty stress on neuroendocrine activities and running performance in thoroughbred horses","volume":"15","author":"Hada","year":"2003","journal-title":"J. Neuroendocrinol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1751-0147-50-6","article-title":"Circulating beta-endorphin, adrenocorticotrophic hormone and cortisol levels of stallions before and after short road transport: Stress effect of different distances","volume":"50","author":"Fazio","year":"2008","journal-title":"Acta Vet. Scand."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"856","DOI":"10.14202\/vetworld.2016.856-861","article-title":"Pituitary-adrenocortical adjustments to transport stress in horses with previous different handling and transport conditions","volume":"9","author":"Fazio","year":"2016","journal-title":"Vet. World"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/vr.119.6.148","article-title":"The sympatho-adrenal system and plasma levels of adrenocorticotropic hormone, cortisol and catecholamines in equine grass sickness","volume":"118","author":"Hodson","year":"1986","journal-title":"Vet. Rec."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.2042-3306.2006.tb05552.x","article-title":"Hormone response to training and competition in athletic horses","volume":"38","author":"Cayado","year":"2006","journal-title":"Equine Vet. J. Suppl."},{"key":"ref_80","unstructured":"Haffner, J.C., Hoffman, R.M., and Grubbs, S.G. (2023, January 3\u20135). A Combined TRH\u2013Insulin Procedure Identifies Pituitary Pars Intermedia Dysfunction and Insulin Dysregulation in Horses. Proceedings of the 5th Global Equine Endocrinology Symposium, Bern, Switzerland."},{"key":"ref_81","unstructured":"Haffner, J.C., Hoffman, R.M., Grubbs, S.T., Shepard, K.N., Neal, D.L., and Pearce, G.L. (2020, January 5\u20139). The thyrotropin releasing hormone procedure produces repeatable ACTH concentrations in PPID-negative and PPID-positive horses. Proceedings of the 66th Annual Convention of the American Association of Equine Practitioners, Las Vegas, NV, USA."},{"key":"ref_82","unstructured":"Fredrick, J., McFarlane, D., and Yang, F. (2014, January 4\u20137). ACTH releasing following TRH stimulation in thrifty horses compared to metabolically normal horses. Proceedings of the ACVIM Forum, Nashville, TN, USA."},{"key":"ref_83","unstructured":"Durham, A.E. (2017, January 3\u20137). Is equine pituitary pars intermedia activity subduced in the spring?. Proceedings of the Dorothy Havemeyer Foundation Equine Endocrinology Summit, Miami, FL, USA."},{"key":"ref_84","unstructured":"Potier, J., and Durham, A.E. (2020, January 7\u20139). The effect of latitide and breed on circannual ACTH concentrations in the UK. Proceedings of the 4th Global Equine Endocrine Symposium, Gut Ising, Germany."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1740-0929.2012.01065.x","article-title":"Comparative endocrinological responses to short transportation of Equidae (Equus asinus and Equus caballus)","volume":"84","author":"Fazio","year":"2013","journal-title":"Anim. Sci. J."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/jvim.15423","article-title":"ECEIM consensus statement on equine metabolic syndrome","volume":"33","author":"Durham","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_87","unstructured":"Bertin, F.R., Bailey, S.R., Burns, T.A., de Laat, M.A., Durham, A.E., Frank, N., Kritchevsky, J., and Menzies-Gow, N.J. (2025, July 17). Recommendations for the Diagnosis and Management of Equine Metabolic Syndrome (EMS) and Insulin Dysregulation. Available online: https:\/\/idppid.com\/sites\/default\/files\/clinical-research\/2024%20EEG%20EMS%20recommendations.pdf."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"105562","DOI":"10.1016\/j.tvjl.2020.105562","article-title":"Efficacy of pergolide for the management of equine pituitary pars intermedia dysfunction: A systematic review","volume":"266","author":"Tatum","year":"2020","journal-title":"Vet. J."},{"key":"ref_89","unstructured":"Beech, J. (2002, January 4\u20138). Comparison of Vitex agnus castus extract and pergolide in treatment of equine Cushing\u2019s syndrome. Proceedings of the 48th Annual Convention of the American Association of Equine Practitioners, Orlando, FL, USA."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2746\/042516402776250333","article-title":"Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing\u2019s disease with cyproheptadine or pergolide","volume":"34","author":"Perkins","year":"2002","journal-title":"Equine Vet. J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"598","DOI":"10.21836\/PEM20100416","article-title":"Equine Cushing\u2019s Syndrome: Long-term effect of Pergolide therapy","volume":"26","author":"Pongratz","year":"2010","journal-title":"Pferdeheilkunde"},{"key":"ref_92","unstructured":"Schott, H., Rapson, J., Marteniuk, J., and Wisner, S. (2014, January 6\u201310). Long-term response of equids with pituitary pars intermedia dysfunction to treatment with pergolide. Proceedings of the 60th Annual convention of The American Association of Equine Practitioners, Salt Lake City, UT, USA."},{"key":"ref_93","first-page":"19","article-title":"Effects of pergolide mesylate on plasma adrenocorticotropic hormone concentration in horses with pituitary pars intermedia dysfunction","volume":"45","author":"Rendle","year":"2013","journal-title":"Equine Vet. J."},{"key":"ref_94","first-page":"23","article-title":"Effective long-term treatment of equine pituitary pars intermedia adenomas with dopamine agonist","volume":"106","author":"Froin","year":"1998","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"105831","DOI":"10.1016\/j.tvjl.2022.105831","article-title":"The effect of pergolide mesylate on adrenocorticotrophic hormone responses to exogenous thyrotropin releasing hormone in horses","volume":"285","author":"Durham","year":"2022","journal-title":"Vet. J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jevs.2013.11.001","article-title":"Comparison of Insulin and Glucose Metabolism in Horses with Pituitary Pars Intermedia Dysfunction Treated Versus Not Treated with Pergolide","volume":"34","author":"Gehlen","year":"2014","journal-title":"J. Equine Vet. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/jvp.12339","article-title":"Pharmacokinetic and pharmacodynamic properties of pergolide mesylate following long-term administration to horses with pituitary pars intermedia dysfunction","volume":"40","author":"McFarlane","year":"2017","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"ref_98","unstructured":"(2025, July 17). Prascend Information (D). Available online: https:\/\/docs.boehringer-ingelheim.com\/AH\/Prascend-Product-Sheet-2023.pdf."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/vr.139.2.41","article-title":"Pergolide treatment for Cushing\u2019s syndrome in a horse","volume":"139","author":"Munoz","year":"1996","journal-title":"Vet. Rec."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.4142\/jvs.2021.22.e64","article-title":"Preliminary study on the effects of pergolide on left ventricular function in the horses with pituitary pars intermedia dysfunction","volume":"22","author":"Gehlen","year":"2021","journal-title":"J. Vet. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jevs.2018.10.004","article-title":"Dopaminergic and Antidopaminergic Effects on Heart Rate in Healthy Horses When Challenged With Brief 2-minute Exercise Bouts","volume":"71","author":"Thompson","year":"2018","journal-title":"J. Equine Vet. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jevs.2012.12.006","article-title":"Inhibitory effects of Pergolide and Cabergoline formulations on daily plasma prolactin concentrations in geldings and on the daily prolactin responses to a small dose of Sulpiride in mares","volume":"33","author":"Hebert","year":"2013","journal-title":"J. Equine Vet. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Sundra, T., Kelty, E., Rossi, G., and Rendle, D. (2024). Retrospective assessment of the use of extended-release cabergoline in the management of equine pituitary pars intermedia dysfunction. Front. Vet. Sci., 11.","DOI":"10.3389\/fvets.2024.1332337"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"106531","DOI":"10.1016\/j.domaniend.2020.106531","article-title":"Effects of pituitary pars intermedia dysfunction and Prascend (pergolide tablets) treatment on endocrine and immune function in horses","volume":"74","author":"Miller","year":"2021","journal-title":"Domest. Anim. Endocrinol."},{"key":"ref_105","first-page":"16","article-title":"Efficacy of a novel palatable pergolide paste formulation for the treatment of pituitary pars intermedia dysfunction (PPID) in ponies","volume":"50","author":"Rendle","year":"2018","journal-title":"Equine Vet. J."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Galinelli, N.C., Bamford, N.J., Erdody, M.L., Mackenzie, S.A., Warnken, T., Harris, P.A., Sillence, M.N., and Bailey, S.R. (2025). Effect of pergolide treatment on insulin dysregulation in horses and ponies with pituitary pars intermedia dysfunction. Equine Vet. J.","DOI":"10.1111\/evj.14468"}],"container-title":["Veterinary Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2306-7381\/12\/8\/780\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:32:14Z","timestamp":1760034734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2306-7381\/12\/8\/780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":106,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["vetsci12080780"],"URL":"https:\/\/doi.org\/10.3390\/vetsci12080780","relation":{},"ISSN":["2306-7381"],"issn-type":[{"value":"2306-7381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}